BCL-2 antagonism sensitises CTL-resistant HIV reservoirs to elimination ex vivo

• R.B. Jones,
• Y. Ren,
• S.H. Huang,
• S. Patel,
• W.C. Alberto,
• D. Magat,
• D. Ahimovic,
• A.B. Macedo,
• A. Bosque,
• C.M. Bollard

Affiliations

R.B. Jones

Infectious Diseases Division, Weill Cornell Medicine, New York, Ny, USA; Dept of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washinton, DC, USA

Y. Ren

Infectious Diseases Division, Weill Cornell Medicine, New York, Ny, USA

S.H. Huang

Infectious Diseases Division, Weill Cornell Medicine, New York, Ny, USA

S. Patel

Childrens National Medical Center, Washington, DC, USA

W.C. Alberto

Infectious Diseases Division, Weill Cornell Medicine, New York, Ny, USA

D. Magat

Infectious Diseases Division, Weill Cornell Medicine, New York, Ny, USA

D. Ahimovic

Infectious Diseases Division, Weill Cornell Medicine, New York, Ny, USA

A.B. Macedo

Dept of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washinton, DC, USA

A. Bosque

Dept of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washinton, DC, USA

C.M. Bollard

Childrens National Medical Center, Washington, DC, USA